(a) Kaplan–Meier estimates of overall survival, (OS, solid line, n=523) and leukemia-free survival (LFS, dotted line, n=282). (b) Kaplan-Meier estimates of overall survival for patients receiving a myeloablative (MAC, dotted line, n=332) or a reduced-intensity (RIC, solid line, n=191) conditioning regimen. (c) Incidence of relapse in patients receiving a MAC (dotted line) or RIC (solid line) conditioning regimen. (d) Non-relapse mortality (NRM) in patients receiving a MAC (dotted line) or RIC (solid line) conditioning regimen. (e) A CIBMTR scoring system validation with overall survival according to the risk score. The hazard ratio and the overall survival for score 2 and 3 proved significantly worse than 1 and 2.